The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y. Q.
Right arrow Articles by Ferrante, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y. Q.
Right arrow Articles by Ferrante, A.
The Journal of Immunology, 1999, 162: 3316-3320.
Copyright © 1999 by The American Association of Immunologists

Regulation of Lymphotoxin Production by the p21ras-raf-MEK-ERK Cascade in PHA/PMA-Stimulated Jurkat Cells1

Yong Q. Li*, Charles S. T. Hii2,*, Maurizio Costabile*, David Goh*, Channing J. Der{dagger} and Antonio Ferrante*

* Department of Immunopathology, Women’s and Children’s Hospital, North Adelaide, Australia; and {dagger} Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599

Although the production of lymphotoxin (LT) from activated Th1 lymphocytes has been reported extensively, the intracellular signaling mechanisms that regulate this T cell function remain totally undefined. We have examined whether the p21ras-raf-1-mitogen-activated protein kinase/extracellular signal-regulated protein kinase (ERK) kinase (MEK)-ERK cascade plays a role in regulating the production of LT, because the activity of these signaling molecules is up-regulated in activated T lymphocytes. Transfection of Jurkat leukemic T cells with a dominant negative mutant of p21ras (ras17N or ras15A), raf-1 (raf 1–130), or ERK1 (Erk1-K71R) resulted in the suppression of the mitogen/phorbol ester-stimulated production/secretion of LT. This suppression was accompanied by a parallel inhibition of mitogen-stimulated ERK activation. The selective antagonist of MEK1 activation, PD98059, also attenuated the mitogen-stimulated or anti-CD3 Ab and phorbol ester-stimulated production of LT from Jurkat cells or peripheral blood T lymphocytes. This study provides, for the first time, direct evidence that the p21ras-raf-MEK-ERK cascade plays a vital role in regulating the production of LT.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-N. Zhu, W.-M. Zhao, Y.-F. Yang, Q.-F. Liu, Y. Zhou, J. Tian, J. Ni, Y.-F. Fu, X.-G. Zhong, W. Tang, et al.
Periplocoside E, an Effective Compound from Periploca sepium Bge, Inhibited T Cell Activation in Vitro and in Vivo
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 662 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Costabile, C. S. T. Hii, M. Melino, C. Easton, and A. Ferrante
The Immunomodulatory Effects of Novel {beta}-Oxa, {beta}-Thia, and {gamma}-Thia Polyunsaturated Fatty Acids on Human T Lymphocyte Proliferation, Cytokine Production, and Activation of Protein Kinase C and MAPKs
J. Immunol., January 1, 2005; 174(1): 233 - 243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Takagi, J. Du, X.-Y. Ma, I. Nakashima, and F. Nagase
Phorbol 12-Myristate 13-Acetate Protects Jurkat Cells from Methylglyoxal-Induced Apoptosis by Preventing c-Jun N-Terminal Kinase-Mediated Leakage of Cytochrome c in an Extracellular Signal-Regulated Kinase-Dependent Manner
Mol. Pharmacol., March 1, 2004; 65(3): 778 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-W. Lee, D.-H. Ahn, S. C. Crawley, J.-D. Li, J. R. Gum Jr., C. B. Basbaum, N. Q. Fan, D. E. Szymkowski, S.-Y. Han, B. H. Lee, et al.
Phorbol 12-Myristate 13-Acetate Up-regulates the Transcription of MUC2 Intestinal Mucin via Ras, ERK, and NF-kappa B
J. Biol. Chem., August 30, 2002; 277(36): 32624 - 32631.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Costabile, C. S. T. Hii, B. S. Robinson, D. A. Rathjen, M. Pitt, C. Easton, R. C. Miller, A. Poulos, A. W. Murray, and A. Ferrante
A Novel Long Chain Polyunsaturated Fatty Acid, {beta}-Oxa 21:3n-3, Inhibits T Lymphocyte Proliferation, Cytokine Production, Delayed-Type Hypersensitivity, and Carrageenan-Induced Paw Reaction and Selectively Targets Intracellular Signals
J. Immunol., October 1, 2001; 167(7): 3980 - 3987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.